Terms: = Ovarian cancer AND SSX4, MGC119056, 6759, ENSG00000204645, O60224, MGC12411
3 results:
1. Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for ovarian cancer.
Falcetta F; Bizzaro F; D'Agostini E; Bani MR; Giavazzi R; Ubezio P
Cancer Res; 2017 Dec; 77(23):6759-6769. PubMed ID: 28951463
[TBL] [Abstract] [Full Text] [Related]
2. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
Valmori D; Qian F; Ayyoub M; Renner C; Merlo A; Gnjatic S; Stockert E; Driscoll D; Lele S; Old LJ; Odunsi K
Clin Cancer Res; 2006 Jan; 12(2):398-404. PubMed ID: 16428478
[TBL] [Abstract] [Full Text] [Related]
3. SSX expression in gynecological cancers and antibody response in patients.
Hasegawa K; Koizumi F; Noguchi Y; Hongo A; Mizutani Y; Kodama J; Hiramatsu Y; Nakayama E
Cancer Immun; 2004 Dec; 4():16. PubMed ID: 15603546
[TBL] [Abstract] [Full Text] [Related]
